China’s NMPA is proposing to cut down the clinical trial review waiting period for novel medicines to 30 working days from the current 60.

Alzheimer’s drug developers are now at the forefront of adopting more nuanced, cost-effective, and patient-centric clinical trial designs.

Gain insights to de-risk and accelerate your trials. Explore with us the value of integrating precision medicine into your clinical trials — from patient selection to operational efficiency.

Ocugen, Inc. Announces U.S. FDA Clearance of Investigational New Drug Amendment to Initiate Phase 2/3 Pivotal Confirmatory Clinical Trial of OCU410ST—Modifier Gene Therapy Candidate for ...

The REPORT guide is a ‘How to’ guide to help you report your clinical research in an effective and transparent way. It is intended to supplement established first choice reporting tools, such as ...

Please provide your email address to receive an email when new articles are posted on . Semaglutide lowered risk for kidney outcomes consistently across BMI subgroups in the FLOW trial. Body ...

Of note, many participants reported significant social and financial vulnerabilities that might have excluded them from transplant access outside the setting of a clinical trial. Beyond race and ...